RO121270B1 - Taxani substituiţi cu esteri în poziţia c10, ca agenţi antitumorali - Google Patents

Taxani substituiţi cu esteri în poziţia c10, ca agenţi antitumorali Download PDF

Info

Publication number
RO121270B1
RO121270B1 ROA200101083A RO200101083A RO121270B1 RO 121270 B1 RO121270 B1 RO 121270B1 RO A200101083 A ROA200101083 A RO A200101083A RO 200101083 A RO200101083 A RO 200101083A RO 121270 B1 RO121270 B1 RO 121270B1
Authority
RO
Romania
Prior art keywords
pyridyl
thienyl
furyl
cox
substituted
Prior art date
Application number
ROA200101083A
Other languages
English (en)
Romanian (ro)
Inventor
A. Holton Robert
Original Assignee
Florida State University Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University Research Foundation, Inc. filed Critical Florida State University Research Foundation, Inc.
Publication of RO121270B1 publication Critical patent/RO121270B1/ro

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/75Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ROA200101083A 2000-02-02 2001-02-02 Taxani substituiţi cu esteri în poziţia c10, ca agenţi antitumorali RO121270B1 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17978200P 2000-02-02 2000-02-02
PCT/US2001/003623 WO2001057032A1 (en) 2000-02-02 2001-02-02 C10 ester substituted taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
RO121270B1 true RO121270B1 (ro) 2007-02-28

Family

ID=22657972

Family Applications (1)

Application Number Title Priority Date Filing Date
ROA200101083A RO121270B1 (ro) 2000-02-02 2001-02-02 Taxani substituiţi cu esteri în poziţia c10, ca agenţi antitumorali

Country Status (25)

Country Link
EP (1) EP1165553B1 (enExample)
JP (1) JP2003522172A (enExample)
CN (1) CN1380882A (enExample)
AT (1) ATE432928T1 (enExample)
AU (1) AU782150B2 (enExample)
BG (1) BG64889B1 (enExample)
BR (1) BR0104354A (enExample)
CA (1) CA2368274C (enExample)
CZ (1) CZ20013430A3 (enExample)
DE (1) DE60138853D1 (enExample)
GE (1) GEP20043323B (enExample)
HU (1) HUP0600302A2 (enExample)
IL (1) IL145638A (enExample)
MX (1) MXPA01009905A (enExample)
NO (1) NO327910B1 (enExample)
NZ (1) NZ514382A (enExample)
PL (1) PL202957B1 (enExample)
RO (1) RO121270B1 (enExample)
RU (1) RU2262506C2 (enExample)
SK (1) SK13692001A3 (enExample)
TR (1) TR200102858T1 (enExample)
TW (1) TWI299732B (enExample)
UA (1) UA75039C2 (enExample)
WO (1) WO2001057032A1 (enExample)
ZA (1) ZA200108055B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
SG129990A1 (en) * 2001-08-01 2007-03-20 Univ Florida State Res Found C10 ester substituted taxanes
PE20050693A1 (es) 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
WO2006088767A2 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C(10)エチルエステルおよびc(10)シクロプロピルエステル置換タキサン

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
IL109051A0 (en) * 1993-03-22 1994-06-24 Univ Florida State Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
DK0690867T3 (da) * 1993-03-22 2003-06-10 Univ Florida State Taxaner med furyl- eller thienylsubstitueret sidekæde
CA2158863C (en) * 1993-03-22 2006-12-19 Robert A. Holton Taxanes having a pyridyl substituted side-chain
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
JPH10508022A (ja) * 1994-10-28 1998-08-04 ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
DK0914116T3 (da) * 1996-05-22 2000-11-20 Protarga Inc Kompositstoffer omfattende konjugater af cis-docosahexaensyre og Taxotere
AU758418B2 (en) * 1997-12-19 2003-03-20 Kabushiki Kaisha Yakult Honsha Taxane derivatives
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
BR0104354A (pt) 2002-01-02
TWI299732B (en) 2008-08-11
PL202957B1 (pl) 2009-08-31
HUP0600302A2 (en) 2006-07-28
AU782150B2 (en) 2005-07-07
RU2262506C2 (ru) 2005-10-20
PL351380A1 (en) 2003-04-07
GEP20043323B (en) 2004-02-10
SK13692001A3 (sk) 2002-07-02
NO20014754L (no) 2001-11-29
CN1380882A (zh) 2002-11-20
CA2368274C (en) 2009-10-13
JP2003522172A (ja) 2003-07-22
IL145638A0 (en) 2002-06-30
TR200102858T1 (tr) 2002-12-23
NO20014754D0 (no) 2001-10-01
NO327910B1 (no) 2009-10-19
CA2368274A1 (en) 2001-08-09
UA75039C2 (en) 2006-03-15
NZ514382A (en) 2004-05-28
BG105965A (en) 2002-07-31
ZA200108055B (en) 2003-12-01
DE60138853D1 (de) 2009-07-16
MXPA01009905A (es) 2003-08-20
AU3480901A (en) 2001-08-14
EP1165553B1 (en) 2009-06-03
IL145638A (en) 2011-05-31
ATE432928T1 (de) 2009-06-15
BG64889B1 (bg) 2006-08-31
CZ20013430A3 (cs) 2002-04-17
WO2001057032A1 (en) 2001-08-09
EP1165553A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
RU2265017C2 (ru) С7 сложноэфирзамещенные таксаны в качестве противоопухолевых средств
US20040024051A1 (en) C10 heterosubstituted acetate taxanes
US6660866B2 (en) C10 carbonate substituted taxanes
US6673833B2 (en) C7 heterosubstituted acetate taxanes
US6780879B2 (en) C7 carbonate substituted taxanes
US7524869B2 (en) Taxanes having a C10 ester substituent
RO121270B1 (ro) Taxani substituiţi cu esteri în poziţia c10, ca agenţi antitumorali
US6596737B2 (en) C10 carbamoyloxy substituted taxanes
US6359154B2 (en) C7 carbamoyloxy substituted taxanes